| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/10/2008 | EP1062232B1 Molecules that home to various selected organs or tissues |
| 09/10/2008 | EP0986314B1 Probiotic lactic acid bacterium to treat bacterial infections associated with sids |
| 09/10/2008 | EP0944389B1 Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors |
| 09/10/2008 | EP0901371B1 Alteration of microbial populations in the gastrointestinal tract |
| 09/10/2008 | EP0871376B1 Use of locally administered lysine for enhancing vascular fonction |
| 09/10/2008 | CN101263146A 8-methoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones and related compounds as anti-infective agents |
| 09/10/2008 | CN101263145A 4-amino-thieno[3,2-C] pyridine-7-carboxylic acid derivatives |
| 09/10/2008 | CN101263144A New pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives |
| 09/10/2008 | CN101263143A Crystalline forms of a pyrrolotriazine compound |
| 09/10/2008 | CN101263142A RAF inhibitor compounds and methods of use thereof |
| 09/10/2008 | CN101263141A Hydantoin compounds |
| 09/10/2008 | CN101263140A Heterobicyclic compounds as glucokinase activators |
| 09/10/2008 | CN101263139A Isoxazolo derivatives as GABA A alpha5 inverse agonists |
| 09/10/2008 | CN101263138A Salicylate and gentisate salts of a piperazine compound |
| 09/10/2008 | CN101263136A Benzimidazole derivatives as 5-HT6, 5-HT24 |
| 09/10/2008 | CN101263135A Modulators of metabolism and the treatment of disorders related thereto |
| 09/10/2008 | CN101263134A Midazole-4-carboxamide derivatives for use as CB modulators |
| 09/10/2008 | CN101263133A New pyridine analogues |
| 09/10/2008 | CN101263131A Urea glucokinase activators |
| 09/10/2008 | CN101263130A 2-aniline-4-aryl substituted thiazole derivatives |
| 09/10/2008 | CN101263127A Piperazine derivatives |
| 09/10/2008 | CN101263124A Quinazoline derivatives useful in cancer treatment |
| 09/10/2008 | CN101263122A 1,2-diarylimidazoles for use as CB1 modulators |
| 09/10/2008 | CN101263120A 4,5-dihydro-1h-pyrazole derivatives, their preparation and use as medicaments |
| 09/10/2008 | CN101263119A Novel 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 09/10/2008 | CN101263115A Substituted indoles and use thereof |
| 09/10/2008 | CN101263114A Crystalline and amorphous sodium atorvastatin |
| 09/10/2008 | CN101263112A Histamine H3 receptor agents, preparation and therapeutic uses |
| 09/10/2008 | CN101263111A Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-beta-azetidinone, an intermediate for the synthesis of ezetimibe |
| 09/10/2008 | CN101263107A Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
| 09/10/2008 | CN101262906A JNK inhibitors for the treatment of endometreosis |
| 09/10/2008 | CN101262890A Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
| 09/10/2008 | CN101262887A Prevention and treatment of ophthalmic complications of diabetes |
| 09/10/2008 | CN101262886A Formulation and method for administration of ophthalmologically active agents |
| 09/10/2008 | CN101262878A Therapeutic combination of HAMLET and a HDAC inhibitor to treat cancer |
| 09/10/2008 | CN101262871A Compositions and methods for topical treatment of skin infection |
| 09/10/2008 | CN101262870A Methods of reducing the severity of oral and gastrointestinal mucositis |
| 09/10/2008 | CN101262869A Multiple sclerosis therapy and diagnosis |
| 09/10/2008 | CN101262868A Sustained-release formulation comprising a glucuronate salt of a piperazine compound and uses thereof |
| 09/10/2008 | CN101262867A MAO-B inhibitors useful for treating obesity |
| 09/10/2008 | CN101262866A Hemodynamics improving agent |
| 09/10/2008 | CN101262865A Use of at least one 2-alkyl furan, as depigmenting or lightening active principle |
| 09/10/2008 | CN101262864A Alcanoic acid amides substituted by saturated O-heterocycles |
| 09/10/2008 | CN101262863A Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions |
| 09/10/2008 | CN101262862A Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof |
| 09/10/2008 | CN101262861A Pharmaceutical for use in prevention and/or treatment of bowel disease |
| 09/10/2008 | CN101262860A Nanoparticulate acetaminophen formulations |
| 09/10/2008 | CN101262859A Conjugated aromatic compounds for diagnosis and therapy |
| 09/10/2008 | CN101262858A Adhesive medicament preparation containing bisoprolol |
| 09/10/2008 | CN101262857A 3-(2-dimethylaminomethyl cyclohexyl) phenol retard formulation |
| 09/10/2008 | CN101262856A Crystalline trihydrate of zoledronic acid |
| 09/10/2008 | CN101262855A Method of treatment or prevention of age-related macular degeneration |
| 09/10/2008 | CN101262853A Stable pharmaceutical composition comprising linezolid form IV |
| 09/10/2008 | CN101262848A Antifungal composition |
| 09/10/2008 | CN101262847A Stable pharmaceutical composition comprising a pyrimidine-sulfamide |
| 09/10/2008 | CN101262846A Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof |
| 09/10/2008 | CN101262783A Nutritional supplement for a category of HIV patients |
| 09/10/2008 | CN101262763A Methods of treating cancer and other conditions or disease states using LFMAU and LDT |
| 09/10/2008 | CN101260148A Hybrid and tandem expression of neisserial proteins |
| 09/10/2008 | CN101260136A Oestrogen derivatives as inhibitors of steroid sulphatase |
| 09/10/2008 | CN101260121A Complex compound of heteroaromatic thiosemicarbazone and transition metal, and application thereof in preparing antineoplastic medicine |
| 09/10/2008 | CN101260115A Polymorphous forms of rifaximin, preparation and application thereof used in pharmaceutical preparation |
| 09/10/2008 | CN101260114A Polymorphous forms of rifaximin, preparation and application thereof used in pharmaceutical preparation |
| 09/10/2008 | CN101260112A Acethydrazide derivatives containing thieno[3.2-c]pyridine, preparation method and use thereof |
| 09/10/2008 | CN101260108A Mercaptopyrrolidone carbon penems derivatives |
| 09/10/2008 | CN101260106A Raf kinase inhibitor, preparing method and use thereof |
| 09/10/2008 | CN101260104A Inhibition of phosphoinositide 3-kinase beta |
| 09/10/2008 | CN101260103A Compound with portion PPARgamma excitant activity and application thereof |
| 09/10/2008 | CN101260102A Antineoplastic activity marine indole alkaloids substances, and preparation method and application thereof |
| 09/10/2008 | CN101260095A 13-halo-3,15-dioxygibberellic acid ester and preparation method thereof |
| 09/10/2008 | CN101260091A Acrylamides compounds containing 1,2,3-thiadiazoles ring and having anti-hepatitis B virus activity |
| 09/10/2008 | CN101260086A Protein-tyrosine-phosphatase 1B inhibitor and its preparation method and use |
| 09/10/2008 | CN101260080A 3-(2-methyl-5-nitorimidazole)-1,2-propyl ester compound and its preparation method and use |
| 09/10/2008 | CN101260077A Quinolin-2-ones derivative, pharmaceutical composition and use thereof |
| 09/10/2008 | CN101260075A Aralkylpiperidine derivative and application thereof in preparing analgesic and sedative medicament |
| 09/10/2008 | CN101260073A Quasi-peptides HIV-1 protease inhibitor, preparation method and use |
| 09/10/2008 | CN101260072A Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| 09/10/2008 | CN101260063A Gamma-aminobutyric acid derivative and its preparing process |
| 09/10/2008 | CN101260050A 氨基链烷醇衍生物 Amino alkanol derivative |
| 09/10/2008 | CN101260040A 5/7/6 type taxane diterpenoid, and medicament composition, synthesizing method and use thereof |
| 09/10/2008 | CN101259286A Method for constructing liver target drug-carrying polymer micelle |
| 09/10/2008 | CN101259285A Application of 2-chitosan salicylic acid graft compound in anticoagulant and long-acting ease pain |
| 09/10/2008 | CN101259284A Liver target anticancer nano prodrug system based on tree shaped polymer, preparation and use |
| 09/10/2008 | CN101259283A Anti-depression noncovalent complex with high dissolvability and preparation thereof |
| 09/10/2008 | CN101259279A Biocompatibile monodisperse nano polymer carrier and its preparation and medicine-carrying method |
| 09/10/2008 | CN101259278A Optimum matching multiple water-soluble vitamin medicinal composition containing high-efficiency bacteriostat and preparation thereof |
| 09/10/2008 | CN101259276A Method of selecting substance characterized by assaying PPARdelta activating effect and drug |
| 09/10/2008 | CN101259265A Deep-sea fish collagen oral liquid |
| 09/10/2008 | CN101259262A Inhalation for improving immunity and preparation thereof |
| 09/10/2008 | CN101259260A Quality detecting method of Chinese medicine for treating chronic atrophic gastritis |
| 09/10/2008 | CN101259236A Preparations for treating toxic chemicals smell poisoning and preparation thereof |
| 09/10/2008 | CN101259222A Medicaments for treating bone fracture bone fracture disease |
| 09/10/2008 | CN101259206A Medicine for curing oral ulcer |
| 09/10/2008 | CN101259191A Fat-reducing health products and producing method thereof |
| 09/10/2008 | CN101259183A Externally-applied chinese herbal medicine for treating skin pruritic disease and preparation thereof |
| 09/10/2008 | CN101259181A Preparation of qinkailing freeze-dried injection |
| 09/10/2008 | CN101259179A Chinese medicine í«naodeshengí» soft capsule and preparation thereof |
| 09/10/2008 | CN101259177A Medicaments for treating chronic bronchitis and confecting method thereof |
| 09/10/2008 | CN101259176A Blackberry capsule for treating gout and preparation thereof |
| 09/10/2008 | CN101259169A Proprietary chinese medicine for treating scald and burn and preparation thereof |